WallStreetZenWallStreetZen

NYSE: CHE
Chemed Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CHE past earnings growth

How has CHE's earnings growth performed historically?
Company
8.31%
Industry
8.69%
Market
62.15%
CHE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CHE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CHE's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CHE past revenue growth

How has CHE's revenue growth performed historically?
Company
6.06%
Industry
8.52%
Market
17.33%
CHE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CHE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CHE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CHE earnings and revenue history

Current Revenue
$2.3B
Current Earnings
$272.5M
Current Profit Margin
12%
CHE's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CHE Return on Equity

Current Company
27.5%
Current Industry
-82.7%
Current Market
188%
CHE's Return on Equity (27.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CHE announces earnings.

CHE Return on Assets

Current Company
17.7%
Current Industry
5.7%
CHE is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CHE Return on Capital Employed

Current Company
26.07%
Current Industry
11.9%
CHE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CHE vs Medical Care Facility Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CHE$2.26B$414.34M$272.51M+4.90%+7.19%
THC$20.56B$2.69B$611.00M+2.35%+42.58%
EHC$4.80B$1.01B$463.00M+2.34%+3.33%
UHS$14.28B$1.71B$717.80M+5.80%+4.39%
DVA$12.14B$2.06B$691.54M+1.26%+52.30%
View Top Medical Care Facility Stocks

CHE earnings dates

Next earnings date
Apr 25, 2024

Chemed Earnings & Revenue FAQ

What were CHE's earnings last quarter?

On Invalid Date, Chemed (NYSE: CHE) reported Q4 2023 earnings per share (EPS) of $5.97, up 43.17% year over year. Total Chemed earnings for the quarter were $90.05 million. In the same quarter last year, Chemed's earnings per share (EPS) was $4.17.

If you're new to stock investing, here's how to buy Chemed stock.

What was CHE's earnings growth in the past year?

As of Q2 2024, Chemed's earnings has grown 8.31% year over year. This is 0.37 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 8.69%. Chemed's earnings in the past year totalled $272.51 million.

What is CHE's earnings date?

Chemed's earnings date is Invalid Date. Add CHE to your watchlist to be reminded of CHE's next earnings announcement.

What was CHE's revenue last quarter?

On Invalid Date, Chemed (NYSE: CHE) reported Q4 2023 revenue of $585.91 million up 7.18% year over year. In the same quarter last year, Chemed's revenue was $546.65 million.

What was CHE's revenue growth in the past year?

As of Q2 2024, Chemed's revenue has grown 6.06% year over year. This is 2.45 percentage points lower than the US Medical Care Facilities industry revenue growth rate of 8.52%. Chemed's revenue in the past year totalled $2.26 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.